Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc. financial statements

Ernexa Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 14.08M10-K
Cash and equivalentsUSD 1.88M10-Q
Total debtUSD 490KEODHD

Ernexa Therapeutics Inc. financials on 6ix · Ernexa Therapeutics Inc. on 6ix